Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common causes of cancer‐related
deaths globally due, in part, to the majority of patients being diagnosed with intermediate or …
deaths globally due, in part, to the majority of patients being diagnosed with intermediate or …
Biomarkers in hepatocellular carcinoma: diagnosis, prognosis and treatment response assessment
Hepatocellular carcinoma (HCC) is one of the main cancer-related causes of death
worldwide. Thus, there is a constant search for improvement in screening, diagnosis, and …
worldwide. Thus, there is a constant search for improvement in screening, diagnosis, and …
EASL clinical practice guidelines: management of hepatocellular carcinoma
Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-
related death globally. Hepatocellular carcinoma represents about 90% of primary liver …
related death globally. Hepatocellular carcinoma represents about 90% of primary liver …
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC
A Notarpaolo, R Layese, P Magistri, M Gambato… - Journal of …, 2017 - Elsevier
Background & Aims The AFP model was shown to be superior to the Milan criteria for
predicting hepatocellular carcinoma (HCC) recurrence after liver transplantation in a French …
predicting hepatocellular carcinoma (HCC) recurrence after liver transplantation in a French …
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer …
M Ducreux, GK Abou-Alfa, T Bekaii-Saab, J Berlin… - ESMO open, 2023 - Elsevier
Highlights•The incidence of HCC will continue to rise.•HCC is curable at an early
stage.•New locoregional treatments such as radioembolisation are showing impressive …
stage.•New locoregional treatments such as radioembolisation are showing impressive …
[HTML][HTML] Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
JP Arab, M Dirchwolf, MR Álvares-da-Silva… - Annals of …, 2020 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide.
NAFLD is the most frequently diagnosed chronic liver disease, affecting 20–30% of the …
NAFLD is the most frequently diagnosed chronic liver disease, affecting 20–30% of the …
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab
Background Post hoc analyses assessed the prognostic and predictive value of baseline
alpha-fetoprotein (AFP), as well as clinical outcomes by AFP response or progression …
alpha-fetoprotein (AFP), as well as clinical outcomes by AFP response or progression …
[HTML][HTML] Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH)
JP Arab, JP Roblero, J Altamirano, F Bessone… - Annals of hepatology, 2019 - Elsevier
Alcohol-related liver disease (ALD) is a major cause of advanced chronic liver disease in
Latin-America, although data on prevalence is limited. Public health policies aimed at …
Latin-America, although data on prevalence is limited. Public health policies aimed at …
Liver diseases in Latin America: current status, unmet needs, and opportunities for improvement
Purpose of review To assess the current challenges regarding liver diseases, including the
burden of disease, access to care, screening, and treatment needs in Latin America. Recent …
burden of disease, access to care, screening, and treatment needs in Latin America. Recent …
[HTML][HTML] Contemporary applications of Y90 for the treatment of hepatocellular carcinoma
Q Yu, M Khanjyan, N Fidelman… - Hepatology …, 2023 - journals.lww.com
Transarterial radioembolization (TARE) with yttrium-90 (90 Y) microspheres has been widely
adopted for the treatment of HCC. Recent advances in yttrium-90 (90 Y) dosimetry have led …
adopted for the treatment of HCC. Recent advances in yttrium-90 (90 Y) dosimetry have led …